Merck Wins U.S. ZETIA (ezetimibe)/ VYTORIN (ezetimibe/simvastatin) Patent Infringement Lawsuit

Merck, known as MSD outside the United States and Canada, announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in two jointly related patent infringement suits against Mylan Pharmaceuticals Inc. "The court appropriately ruled that the patent for ZETIA and VYTORIN in the U.S. is valid and enforceable," said Bruce N. Kuhlik, executive vice …

Leave a Reply

Your email address will not be published.

*